| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/13/1996 | US5491066 Specifically reacts with active human ceruloplasmin; diagnosis of wilson's disease |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |
| 02/13/1996 | US5490988 Delivery of therapeutic agents to a target site |
| 02/13/1996 | US5490981 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 02/08/1996 | WO1996003646A1 Chelator idac-2 and method for purifying chelator conjugated compounds |
| 02/08/1996 | WO1996003520A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 02/08/1996 | WO1996003504A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/1996 | WO1996003502A2 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003146A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | WO1996003043A1 Human brain specific kinase |
| 02/08/1996 | DE4431300C1 Histological diagnosis of benign and malignant skin lesions |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195309A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 02/08/1996 | CA2194973A1 Retroviral transduction of cells using soluble complement inhibitors |
| 02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
| 02/07/1996 | EP0695750A1 Naphthyridinium derivative, method for its production; antibody against said derivative and the use of said antibody |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695312A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695192A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 02/07/1996 | EP0695191A1 35/31 kDa SUBUNIT OF THE $i(ENTAMOEBA HISTOLYTICA) ADHERENCE LECTIN |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0642664A4 Assays for o?6 -methylguanine-dna methyltransferase. |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/06/1996 | USRE35152 Administering detectably labeled immunoglobulin that accumulates at inflammation site |
| 02/06/1996 | US5489668 Immunoassay reagents and method for determining cyclosporine |
| 02/06/1996 | US5489653 Water-soluble compounds derived from homopolymer or copolymer of maleic anhydride, and applications of the said compounds to supporting biological molecules |
| 02/06/1996 | US5489533 Human intercellular adhesion molecule-2; antiinflammatory agents |
| 02/06/1996 | US5489525 Monoclonal antibodies to prostate cells |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | CA1338032C Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/01/1996 | WO1996002840A1 Method for determining the lysine content of seeds |
| 02/01/1996 | WO1996002647A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | WO1996002645A2 Htk ligand |
| 02/01/1996 | WO1996002576A1 Reconstituted human antibody against human interleukin-8 |
| 02/01/1996 | WO1996002575A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 02/01/1996 | WO1996002574A1 Process for modifying the stability of antibodies |
| 02/01/1996 | WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002559A1 Growth differentiation factor-12 |
| 02/01/1996 | WO1996002552A1 Lung cancer marker |
| 02/01/1996 | WO1996002273A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | WO1996002272A2 Treatment of autoimmune diseases |
| 02/01/1996 | WO1996002265A1 The cellular basis of transplant arteriosclerosis |
| 02/01/1996 | WO1995034655A3 Surface protein of staphylococcus aureus |
| 02/01/1996 | CA2195454A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 02/01/1996 | CA2195403A1 Lung cancer marker |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2195238A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 02/01/1996 | CA2195205A1 Method for determining the lysine content of seeds |
| 02/01/1996 | CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | CA2194955A1 Htk ligand |
| 02/01/1996 | CA2194907A1 Reshaped human antibody against human interleukin-8 |
| 02/01/1996 | CA2194784A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 01/31/1996 | EP0694560A2 Production of antigens of Pasteurella |
| 01/31/1996 | EP0694309A2 Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection |
| 01/31/1996 | EP0694066A1 Model for gonococcal infection |
| 01/31/1996 | EP0694044A1 Method and product for regulating cell responsiveness to external signals |
| 01/31/1996 | EP0694043A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 01/31/1996 | EP0693936A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 01/31/1996 | EP0693925A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/31/1996 | EP0502928B1 Methods of detecting bone resorption in vivo |
| 01/31/1996 | EP0491688B1 Methods for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
| 01/30/1996 | US5487979 DNA encoding human and murine eps15, a substrate for the epidermal growth factor receptor |
| 01/30/1996 | US5487977 Using a single immunoenzymatic elisa assay based on the interaction between one and several monoclonal anti-sulfidoleukotriene antibodies and a sulfidoleukotriene conjugated to a revealing enzyme |
| 01/30/1996 | US5487892 Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| 01/30/1996 | US5487891 Human anti-RH(D) monoclonal antibodies reagents and hybridomas and methods of RH typing using anti-RH(D) monoclonal antibodies and reagents |
| 01/30/1996 | US5487890 Mammalian primate erythrocyte bound heteropolymerized monoclonal antibodies and methods of use thereof |
| 01/30/1996 | CA2129163A1 Immunodetection of rna:dna hybrids for diagnostics |
| 01/30/1996 | CA1338011C Oncostatin m and novel compositions having anti-neoplastic activity |
| 01/25/1996 | WO1996002004A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001845A1 Growth differentiation factor-11 |
| 01/25/1996 | WO1996001839A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | WO1995030439A3 Prevention of tumor metastasis |
| 01/25/1996 | WO1995030438A3 Methods and compositions to enhance endogenous fibrinolytic activity |
| 01/25/1996 | CA2194765A1 Connective tissue growth factor-2 |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | CA2194439A1 Immunoassay for mycophenolic acid |
| 01/25/1996 | CA2194299A1 Novel cytokine designated lerk-5 |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/24/1996 | EP0693687A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693132A1 Rapamycin assay |
| 01/24/1996 | EP0693124A1 Human osteoclast-specific and -related genes |
| 01/24/1996 | EP0693121A1 Monoclonal antibody 88bv59, subclones and method of making |
| 01/24/1996 | EP0693085A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |